Beth Isreal Deaconness Medical Center — Boston, Massachusetts

Beth Isreal Deaconness Medical Center is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.

Beth Isreal Deaconness Medical Center has participated in 2 clinical trials.

Therapeutic areas: Breast Cancer, Lymphoplasmacytic Lymphoma, Waldenstrom's Macroglobulinemia.

Sponsors: Massachusetts General Hospital, Dana-Farber Cancer Institute.

Sponsor Feasibility Report

Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Beth Isreal Deaconness Medical Center?

Beth Isreal Deaconness Medical Center has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Beth Isreal Deaconness Medical Center conducted?

Beth Isreal Deaconness Medical Center has 2 clinical trials on record. Their work covers Breast Cancer, Lymphoplasmacytic Lymphoma, Waldenstrom's Macroglobulinemia.

Is Beth Isreal Deaconness Medical Center accredited by Crixeo Health?

Beth Isreal Deaconness Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Beth Isreal Deaconness Medical Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.